Corporate news
|
Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET
HOLLISTON, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience , Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended December 31, 2025, before the market opens on March 12, 2026, and will hold a conference call to discuss the...
|
|
Spectral Medical Provides Update on PMA Submission Timing for PMX-20R
TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update on the timing of its Premarket Approval...
|
|
Intellia Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates
HAELO Phase 3 clinical data for lonvo-z in HAE expected by mid-2026; BLA submission in second half of 2026; anticipated U.S. launch in first half of 2027 Process underway to reactivate global sites for MAGNITUDE-2 Phase 3 clinical trial of nex-z in ATTRv-PN;enrollment...
|
|
Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results
– Generated Quarterly Net Revenues of $205.4 Million, Up 13% Year-over-Year, and Record Full-Year Net Revenues of $780.6 Million, Up 24% Year-over-Year – – Generated Record Quarterly and Full-Year Jornay PM® Net Revenue of $45.9 Million and $148.9 Million, Up...
|
|
Colliers named to IAOP’s Global 100 for 20th consecutive year
Two decades of global service excellence underscore Colliers’ commitment to client success TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Colliers (NASDAQ, TSX: CIGI), a leading diversified professional services and investment management company, has been namedto...
|
|
Xtract One Selected by the British Museum to Deliver Advanced, High-Throughput Security Across the World-Renowned Institution
TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its Xtract One SmartGateway (“SmartGateway”) system has been selected by the British Museum to protect all venue...
|
|
Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Established partnership with Kelun-Biotech expanding pipeline and accelerating combination strategy with CR-001, PD-1 x VEGF bispecific antibody, and multiple ADCs ASCEND Phase 1/2 global clinical trial underway to evaluate CR-001 in advanced solid tumors with...
|
|
Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
On track for INLIGHT clinical data update in 1Q 2026; fat loss similar to GLP-1 observed at three months and expected to continue over time and with higher doses of WVE-007 (INHBE GalNAc-siRNA), while preserving muscle mass Planning underway to initiate Phase...
|
|
Tris Pharma to Present Debut Data from Phase 3 ALLEVIATE 1-2 Trials Evaluating Cebranopadol in Acute Pain at AAPM PainConnect 2026 Annual Meeting
Cebranopadol is an investigational first-of-its kind dual NOP/MOP receptor (NMR) agonist which uses a novel approach of activating NOP and MOP receptors to work synergistically to modulate pain ALLEVIATE-1 and ALLEVIATE-2 studies evaluated the safety and efficacy...
|
|
Wrap Expedites Drone-Based Non-Lethal Technologies; Strengthens Commitment with K-Form, Inc.
Signed Purchase Orders for DFR-X Systems Advance the Development of Wrap’s Drone First Responder Interdiction Platform MIAMI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or the “Company”), a global leader in Non-Lethal Response...
|
|
Rio Silver Secures Community Permission to Commence Site Activities at Maria Norte, Peru
Local Community Support Advances Silver-Dominant Maria Norte Toward Access and Development Execution VANCOUVER, British Columbia, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Rio Silver Inc. (“Rio Silver” or the “Company”) (TSX-V: RYO | OTC: RYOOF) is pleased to announce...
|
|
FTI Consulting Reports Fourth Quarter and Full Year 2025 Financial Results
Fourth Quarter 2025 Record Revenues of $990.7 Million, Up 11% Compared to $894.9 Million in Prior Year Quarter Fourth Quarter 2025 EPS and Adjusted EPS of $1.78, Up 29% and 14%, Compared to EPS of $1.38 and Adjusted EPS of $1.56 in Prior Year Quarter Full Year...
|
|
Consolidated Lithium Metals Announces $17.07 Million Private Placement Financing
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Consolidated Lithium Metals Inc. (TSXV: CLM | FRA: Z36 | OTCQB: JORFF) (“CLM” or the “Company”) announces today that itintends...
|
|
Vera Therapeutics Provides Business Update and Reports Full Year 2025 Financial Results
Positive Phase 3 data from ORIGIN 3 study of atacicept in IgA nephropathy (IgAN) presented at American Society of Nephrology (ASN) Kidney Week and published in the New England Journal of Medicine U.S. Food and Drug Administration (FDA) granted priority review...
|
|
[Latest] Global Laboratory Informatics Market Size/Share Worth USD 8.21 Billion by 2035 at a 5.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Laboratory Informatics Market size & share revenue was valued at approximately USD 4.89 Billion in 2025 and is expected to reach...
|
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x |
©2026 ValueSpectrum. All Rights Reserved
Developed and maintained by 